📰 13 sources covering this story

Brazil Approves Its First Locally Made Generic of Semaglutide, the Ozempic Weight-Loss Drug

First covered 3 days ago · latest take 2 hrs ago. Compare how each outlet is covering it — and rate the sources you trust.

Brazil Approves Its First Locally Made Generic of Semaglutide, the Ozempic Weight-Loss Drug
The Rio Times
The Rio Times2 hrs ago
Brazil Approves Its First Locally Made Generic of Semaglutide, the Ozempic Weight-Loss Drug
Anvisa has cleared Brazil's first true generic semaglutide pen from EMS, alongside a Germed copy, opening a home-grown price fight over the Ozempic molecule.
Quartz
Quartz5 hrs ago
Nestlé is using AI to build a new line of food products for weight loss drug users
The company says AI tools are helping it analyze clinical research and identify nutrients to address side effects like muscle loss
CTV News
CTV News7 hrs ago
Nestle looks to develop new products to serve users of weight-loss drugs
Nestle is seeking to turn the rise of GLP-1 weight-loss drugs from a threat into a business opportunity, using artificial intelligence and nutritional science to develop products aimed at millions of consumers taking medicines such as Ozempic and Wegovy.
Irish News
Irish News8 hrs ago
Nestle looks to develop new products to serve users of weight-loss drugs
Nestle executive says rapid rise of weight-loss drugs creates opportunity
BBC News
BBC News13 hrs ago
Why don't men talk about using weight-loss drugs?
Some men say they feel ashamed of needing to use weight-loss injections as it seems like "cheating".
Birmingham Live
Birmingham Live1 days ago
Pension mistake costing high-earners £400,000 in retirement savings
The firm's calculations show that workers on median salaries stand to lose approximately £163,000
The Hindu
The Hindu1 days ago
Telangana brings food safety, drugs control under administrative roof of ‘TG SAFE’
The government has appointed 2005-batch IPS officer Avinash Mohanty, who was serving as Director General of the DCA, as Commissioner of TG SAFE, in addition to his existing duties.
Vox
Vox2 days ago
Ozempic is not just a weight-loss story anymore
Just last month, I marked my 25th year as a professional journalist, which I guess means my journalistic career is old enough to rent a car, no questions asked. Work in the news for that long, and you’ll occasionally find yourself surprised by things you published in the past. Like, I had all but forgotten that I had w
The Guardian
The Guardian2 days ago
‘A tax on being thin’: only high earners make overall savings on food bills from weight-loss drugs
Users need discretionary income of nearly £100,000 a year to make savings on their grocery spend after paying £1,200 for GLP-1s, analysis finds The high cost of weight-loss medication is a “regressive tax on being thin” because the outlay outweighs any saving on food costs for all but the highest earners. Someone needs
RTÉ News
RTÉ News2 days ago
Weight loss drugs - can the demand be contained?
Weight loss drugs are effectively the blockbuster drugs of the modern era.
Marca
Marca2 days ago
Phoebe Gates: Does her biggest business controversy show the weight of being Bill Gates’ daughter?
Phoebe Gates: Does her biggest business controversy show the weight of being Bill Gates’ daughter?  MARCA
New York Post
New York Post🏁 first to report3 days ago
Kickstart GLP-1 weight loss for just $99/month — without the hassle of a doctor’s visit
New York Post Composite Starting on a GLP-1 medication can seem intimidating — not to mention expensive. But it doesn’t have to be. Arbor offers two of the most popular, doctor-prescribed GLP-1 weight loss treatments at locked-in prices, even if your dose changes. Plans start at $99/month, a stark difference from the $